[{"orgOrder":0,"company":"International Centre for Diarrhoeal Disease Research, Bangladesh","sponsor":"University of Washington | GSK | Tres Cantos Open Lab Foundation","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"BANGLADESH","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Tebipenem Pivoxil","moa":"Bacterial penicillin-binding protein","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"International Centre for Diarrhoeal Disease Research, Bangladesh","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Centre for Diarrhoeal Disease Research, Bangladesh \/ University of Washington | GSK | Tres Cantos Open Lab Foundation","highestDevelopmentStatusID":"8","companyTruncated":"International Centre for Diarrhoeal Disease Research, Bangladesh \/ University of Washington | GSK | Tres Cantos Open Lab Foundation"}]

Find Clinical Drug Pipeline Developments & Deals for Tebipenem Pivoxil

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          International Centre for Diarrhoeal Disease Research, Bangladesh

                          Country arrow
                          The MedTech Conference
                          Not Confirmed

                          International Centre for Diarrhoeal Disease Research, Bangladesh

                          Country arrow
                          The MedTech Conference
                          Not Confirmed

                          Details : Tebipenem Pivoxil is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dysentery, Bacillary.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          November 16, 2021

                          Lead Product(s) : Tebipenem Pivoxil

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase II

                          Sponsor : University of Washington | GSK | Tres Cantos Open Lab Foundation

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank